Considering the heterogeneity of mechanisms of coagulation activation in inflammatory conditions, our study aimed to explore whether Angiopoietin/Tie2 pathway mediators, which are well-known biomarkers of severity in COVID-19, are associated with hypercoagulability. This evidence concerns the gene TEK and thrombophilia.